These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 113416)

  • 1. Cytostatic effect of macrophages from non-immunised mice on mastocytoma P-815 cells in vitro.
    Bandlow G; Gröner R
    J Cancer Res Clin Oncol; 1979 Jul; 94(3):225-32. PubMed ID: 113416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine macrophage cytotoxicity induced by mastocytoma cells, cell-free mastocytoma exudates, and extracts.
    Dullens HF; Den Otter W
    Immunopharmacology; 1981 Sep; 3(3):241-51. PubMed ID: 6796544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of peritoneal macrophages in cellular responses to mastocytoma in resistant and susceptible mice.
    Farber P; Specter S; Friedman H
    Adv Exp Med Biol; 1979; 121B():521-30. PubMed ID: 121034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A small molecular weight peptide from P815 mastocytoma cells induces macrophage cytotoxicity.
    Dullens HF; den Otter W
    Immunopharmacology; 1981 Dec; 3(4):309-16. PubMed ID: 6799426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adsorption of suppressor cell activity on mouse macrophage monolayers.
    Argyris BF; Cotellessa A
    Transplantation; 1979 Nov; 28(5):372-6. PubMed ID: 160634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal lysozyme production of peritoneal macrophages from mastocytoma P-815 bearing C3D2F1-mice.
    Bandlow G; Kühne J
    Med Microbiol Immunol; 1980 Feb; 168(1):55-62. PubMed ID: 6770238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and cancer, the mastocytoma P815 tumor model revisited: triggering of macrophage activation in vivo with pro-tumorigenic consequences.
    Kamate C; Baloul S; Grootenboer S; Pessis E; Chevrot A; Tulliez M; Marchiol C; Viguier M; Fradelizi D
    Int J Cancer; 2002 Aug; 100(5):571-9. PubMed ID: 12124807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor cell threshold required for suppression of macrophage inflammation.
    Normann SJ
    J Natl Cancer Inst; 1978 May; 60(5):1091-6. PubMed ID: 417187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T cell responses to a syngeneic tumour: conditions for primary activation in vitro.
    Warren HS; Woolnough JA; Lafferty KJ
    Aust J Exp Biol Med Sci; 1978 Apr; 56(2):247-51. PubMed ID: 98140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
    Leu RW; Leu NR; Shannon BJ; Fast DJ
    J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of poly I:C-activated peritoneal cells on the take of transplantable murine tumours.
    Minárovits J; Karczag E; Földes I
    Acta Microbiol Hung; 1987; 34(3-4):197-205. PubMed ID: 3129897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection of DBA/2 or C3H/HeJ mice by intraperitoneal injection of vaccinia virus elicits activated macrophages, cytolytic and cytostatic for S91-melanoma tumor cells.
    Natuk RJ; Byrne JA; Holowczak JA
    Cancer Immunol Immunother; 1986; 22(3):197-203. PubMed ID: 3731205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of tumor-cytostatic macrophages with the antitumor agent 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazole-2-yl)hydrazone] dihydrochloride (bisantrene).
    Wang BS; Lumanglas AL; Ruszala-Mallon VM; Durr FE
    Cancer Res; 1984 Jun; 44(6):2363-7. PubMed ID: 6426780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The paradoxical effects of thioglycollate-induced macrophages on the growth of B16 melanoma cells in vivo and in vitro.
    Miyasaka M; Takiguchi T; Konda S
    Gan; 1980 Jun; 71(3):293-9. PubMed ID: 7418974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of thymocyte mitogenic protein secretion and of cytostatic activity of mouse peritoneal macrophages by trehalose dimycolate and muramyldipeptide.
    Tenu JP; Lederer E; Petit JF
    Eur J Immunol; 1980 Aug; 10(8):647-53. PubMed ID: 6772453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Humoral mechanisms of in vitro inhibition of mouse lymphocyte immunoreactivity by mastocytoma P815 cells].
    Medvedev AE
    Biull Eksp Biol Med; 1988 Jun; 105(6):701-3. PubMed ID: 2968820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity and hydrogen peroxide release by macrophages elicited by trehalose diesters.
    Lepoivre M; Tenu JP; Lemaire G; Petit JF
    J Immunol; 1982 Aug; 129(2):860-6. PubMed ID: 6806386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of the cell-mediated immune response. I. The number of cytolytically active mouse lymphoid cells induced by immunization with allogeneic mastocytoma cells.
    Henney CS
    J Immunol; 1971 Dec; 107(6):1558-66. PubMed ID: 5000987
    [No Abstract]   [Full Text] [Related]  

  • 19. Mastocytoma-induced suppression of in vitro antibody formation.
    Kamo I; Kateley J; Freidman H
    Proc Soc Exp Biol Med; 1975 Mar; 148(3):883-6. PubMed ID: 805435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. IV. Lymph node immunoreactivity and cell-mediated cytotoxicity.
    Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
    Neoplasma; 1987; 34(4):431-9. PubMed ID: 3116439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.